Scientific Publications

Vaccine Genetic Immunity's Press Release: "IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine" ( Click here to read details... ) www.elsevier.com/locate/vaccine (2008)

AIDS Vaccines 2005: "HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3" Montreal, Canada (2005)

Immunologic Activation: Rational Design of Vaccines and Immunotherapeutics. "Therapeutic dendritic cell vaccination in chronic HIV infection", Jean-Marie Andrieu, discussant Julianna Lisziewicz. Stockholm (2005)

HIV DART: Frontiers in drug development for antiretroviral therapies. "Impaired antigen presentation by CD4 T cells and its therapeutic implications" Jamaica, West Indies (2004)

12th Annual Congress in Immunology. "Non-APC Mediated HIV-1 Exogenous Antigen Presentation to CD8 T cells by uninfected CD4 T cells: a Novel Pathogenic Mechanism of HIV/AIDS can be corrected by Therapeutic Immunization" Montreal, Canada (2004)

WCVI - Immunization - Great success of medicine. "DermaVir, a novel HIV immunization technology". Tokyo, Japan (2004)

11th conference on Retroviruses and Opportunistic Infections. "CD4-Dependent, non-APC Mediated Antigen Presentation Pathway: a Novel Pathogenetic Mechanism of Chronic HIV Infection Is Corrected by Therapeutic Vaccination". San Francisco (2004)

DNA Vaccines 2004 - The Gene Vaccine Conference. "DermaVir: a novel DNA based topically delivered vaccine". Monte Carlo, Monaco (2004)

Immunomodulating drugs for the treatment of HIV/AIDS. "DermaVir Therapeutic Immunization for HIV-1 Infected Patients". Lake Garda, Italy (2004)

AIDS Vaccine 2004. "Priming with DermaVir induces virus-specific cellular immune responses in uninfected rhesus macaques". Lausanne, Switzerland (2004)

XV International AIDS Conference. "Prophylactic DermaVir vaccination polarizes Th-1 type responses suppressing viral replication in Rhesus Macaques". Bangkok, Thailand (2004)

10th Conference on Retroviruses and Opportunistic Infections. "Specific, Efficient, and Short-lived DNA Expression in Lymph Node Dendritic Cells Mediates DermaVir's Immunotherapeutic Effects" Boston, USA (2003)

Immune reconstitution and control of HIV. "Therapeutic Vaccines in Pre-Clinical Models". Stresa, Lake Maggiore, Italy (2003)

2nd International Symposium on Molecular Diagnostics and Skin Gene Therapy. "Genetic modified dendritic cells to vaccinate against HIV" Dusseldorf, Germany (2003)

Sixth International Congress on Drug Therapy in HIV Infection. "DermaVir: A new topical DNA vaccine for the treatment of HIV/AIDS". Glasgow, United Kingdom (2002)

XIV Annual International AIDS Conference. "Safety, Immunogenicity and Antiviral Efficacy of a New Topical DNA Vaccine in Macaques with Chronic Infection and AIDS". Barcelona, Spain (2002)

9th Conference on Retroviruses and Opportunistic Infections. "Control of Viral Load Rebound during Treatment Interruptions in Macaques with AIDS Induced by a Novel Topical DNA Immunization (DermaVir)" and "A Novel Topical DNA Vaccine (DermaVir) for the Induction of T Cell Immunity" Seattle, USA (2002)

Third World Congress on Vaccines and Immunisation. "Novel dendritic cell-based topical DNA vaccination combined with STI-HAART induced immune control in macaques with AIDS". Opatija, Croatia (2002)

7th International Workshop on Langerhans cells. "DermaVir: A Langerhans Cell-mediated DNA Immunization Technology for the Induction of Cellular Immune Responses". Stresa, Italy (2001)

Vaccine Development and Immunotherapy "Therapeutic Vaccination: a Wide-impact Valuable Option". San Juan, Puerto Rico (2001)

9th Meeting of the European Society of Gene Therapy. "Genetic Immunization to control retrovirus replication in Macaques". Antalya, Turkey (2001)

Project Inform Workshop on Structured Treatment Interruptions. "Predictive Assays - VIR". Chicago, Illinois (2000)

XIII Annual International AIDS Conference. "Novel HIV Vaccine for Induction of T Cell Immunity". Durban, South Africa (2000)

Mater Medical Research Institute 2nd Annual Dendritic Cell Symposium. "Transcutaneous Genetic Modification of Lymph Node Dendritic Cells with Plasmid DNA". Brisbane, Australia (2000)